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Quantitative proteomics is entering its “third generation,” where intricate experimental designs
aim to increase the spatial and temporal resolution of protein changes. This paper re-analyses
multiple internally consistent proteomic datasets generated from whole cell homogenates and
fractionated brain tissue samples providing a unique opportunity to explore the different factors
influencing experimental outcomes. The results clearly indicate that improvements in data
handling are required to compensate for the increased mean CV associated with complex study
design and intricate upstream tissue processing. Furthermore, applying arbitrary inclusion
thresholds such as fold change in protein abundance between groups can lead to unnecessary
exclusion of important and biologically relevant data.
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Proteomics is entering its “third generation,” where MS is
increasingly being used, not only to quantify total protein lev-
els, but also to investigate how proteins within specific cell
types and subcellular organelles respond both spatially and
temporally to a host of experimental stimuli. [1]. As proteomic
studies embark onmore intricate designs, it is essential to re-
evaluate whether the currently used data-handling strategies
remain appropriate. Fundamental weaknesses and arbitrary
design decisions still permeate proteomic research, despite
efforts to improve the rigor of data handling [2–7]. This article
compares primary datasets generated contemporaneously in
our laboratory using peak intensity based LC-MS to provide a
novel perspective on the suitability of various inclusion crite-
ria and data-handling strategies in analyzing third generation
proteomic data.
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Many quantitative LC-MS proteomic studies use an ini-
tial inclusion criterion that proteins should be identified with
two or more peptides. Though seemingly arbitrary, this in-
clusion criterion is important for two reasons: first, removal
of proteins identified with only one peptide increases the re-
liability of LC-MS protein identification and helps avoid false
detections. A single peptide feature may be found in several
proteins or protein isoforms, therefore a truly definitive iden-
tification is less likely [8]. Second, this cut-off of two peptides
for identification purposes significantly reduces the overall
variance within the dataset, defined as the mean of the coeffi-
cient of variances for all proteins in the dataset. This reduction
is variance considerably increases the power to detect subtle
protein changes (Fig. 1). There is clearly a trade-off between
reducing variance and the number of proteins remaining
for analysis. Extending the inclusion criterion to identifica-
tion of proteins with three or more peptides further reduces
variance, however, also drastically reduces the number of
proteins by nearly half of those originally identified by one
peptide.
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Subcellular proteomics will be a dominant theme in third
generation proteomic research, yet sample fractionation can
greatly impact variance within protein datasets. Sample pro-
cessing techniques including the enrichment ofmicrovessels,
mitochondria [9] or whitematter [10] can be used upstream of
proteomic analysis to provide amore in-depth proteomic pro-
file of how individual cell types and subcellular compartments
are responding to experimental stimuli. However, increasing
technicality upstream of protein detection increases the to-
tal variance of the final dataset, as demonstrated by analysis
of our own proteomic data generated using a range of en-
richment techniques (Fig. 2). White matter enrichment via
micropunches of the corpus callosum and microvessel en-
richment using density gradient centrifugation, two intricate
upstream tissue handling techniques, induce a 7 and 15%
increase in total variance in control tissue, respectively, com-
pared to whole brain homogenates. We hypothesise that this
increase in variance might be linked to varying degrees of
protein degradation occurring when samples are handled at
room temperature for extended periods of time. Upstream
tissue processing enriches samples with targeted proteins,
improving the spatial resolution of detected protein changes.
However, the associated increases in variancemake detection
of subtle protein changes more difficult.
The magnitude of the change in protein abundance (fold
change) is a popular but arbitrary inclusion criterion often
used to dissect proteomic data. Analysis of our in vitro human
cell line data shows that employing an arbitrary fold change
value as a data dissection tool can exclude important pro-
teins from the final analysis. This in vitro study investigated
the effects of a global metabolic challenge on mitochondrial
function and cellular proteomics. A total of 958 proteins were
identified with two or more peptides (n = 6/group). A strin-
gent a priori inclusion criterion of a p < 0.01 was set for a
protein change to be deemed significant, resulting in a final
protein list of 193 significantly altered proteins [11] (Fig. 3A).
However, as well as a p-value threshold, many investigators
also utilize a fold change cut-off to rapidly identify the most
“important” protein changes. Datasets with a low overall vari-
ance allow for the detection of subtle protein changes, how-
ever, employing an arbitrary fold change inclusion criterion
such as the popular “minimum 1.5 fold change” on these low
variance datasets excludes the subtle yet significant protein
changes. The fold change cut-off drastically reduces the num-
ber of proteins included in the final analysis and increases the
risk of creating false negatives (Fig. 3A).
A similar analysis of the impact of arbitrary fold change
cut-offs was carried out on the more variable microvessel
extraction data (Fig. 3B). Due to the increased variability of
these data (as shown in Fig. 2C), employing a stringent al-
pha value of p < 0.01 significantly reduces the number of
proteins in the final list for analysis from 653 identified with
two or more peptides to only 12. In this more variable sys-
tem, imposing a 1.5 fold change cut-off has no further effect
on protein number, due to a large fold change required to
overcome the variance for inclusion at the set alpha level. It
is therefore concluded that inclusion of a fold change data
cut-off is either dangerous in the creation of false negatives
(in studies with low overall variance) or irrelevant (in studies
with high overall variance).
Alternatively, power calculations can be used to determine
the magnitude of change required to detect a significant
Figure 1. Variance structure is affected by the number of peptides used for protein identification. (A) Quantifying proteins with at least two
peptides reduces the mean CV by 5% in a human cell line and (B) by 7% in mouse whole brain, reducing the total list of proteins by 31–38%.
More stringent inclusion criteria (>3 peptides) has minimal effect on the variance but reduces the overall protein number by ∼50%. A set
initial inclusion criterion in proteomic data analysis should therefore be protein identification by at least two peptides. Each data point is
the CV of the abundance measurements for each individual protein. The CV is calculated for individual proteins using abundance values
from independent biological replicates.
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Figure 2. Complex tissue processing techniques have a direct effect on the total variance of the dataset. (A) Whole brain tissue samples
show very similar overall CV in both sham and chronic cerebral hypoperfusion groups (17 and 16%, respectively). (B) White matter
dissection introduces more variance into the system (24% for both sham and chronic cerebral hypoperfusion). (C) Technically demanding
techniques such as microvessel dissection further increase variance (32 and 37% in wild type (WT) and transgenic (Tg) mice, respectively).
Independent variables (surgery or transgene) have little effect on the variance structure of the data. The internal consistency of the three
datasets controls for the technical variance introduced by the LC-MS technique, allowing the effect of tissue processing on the total variance
to be assessed. Each data point represents the CV for the abundance measurement of individual proteins across independent replicates in
each study, with the mean CV across all proteins shown.
difference between two populations given the technical and
biological variance [5]. Used a priori, power calculations
are beneficial in study design, guiding decisions regarding
the number of replicates needed to obtain a set level of
power [12]. However, the nature of a priori power calculations
means these calculations are based on an estimate of overall
biological and technical variance. Our analysis reveals that
the CV is highly dependent upon the type of tissue being an-
alyzed and the degree of upstream tissue processing involved
(Fig. 2). Using a CV that is not specific to the dataset to decide
detectable fold change can be problematic, and could lead to
an over- or underestimation of proteins found to be differ-
entially expressed. To ensure maximum accuracy in a priori
power calculations, extensive and specific pilot data should be
obtained.
The question of whether inclusion of fold change cut-offs
in addition to a p-value cut-off adds biological value to
proteomic data remains. To assess this, we identified
two key proteins involved in the endoplasmic reticulum
stress response: glucose regulated protein 78 (GRP78) and
glucose regulated protein 94 (GRP94). In our in vitro study,
experimental intervention with the metabolic challenge of
oxygen-glucose deprivation (OGD) saw significant upregu-
lation of GRP78 and GRP94 (p < 0.01). However, GRP78
underwent a fold change of 1.53, whereas GRP94 only had
a fold change of 1.48 (Fig. 3C and D) [11]. The popular fold
change cut-off of 2 would exclude both of these proteins from
the analysis, and only GRP78 would be included if a fold
change of 1.5 was used. The interplay between these two pro-
teins is integral to the endoplasmic reticulumstress response;
however, one or both of these proteins would be lost from the
final dataset if an arbitrary fold change inclusion criterion
was employed. Temporal evolution of protein level change is
another important factor to be considered in understanding
third generation proteomics. Data from the in vitro study
demonstrate that following 6 h of OGD, small increases in
protein levels of GRP78 and GRP94 predict larger increases
following 18 h OGD (Fig. 3C and D). These results suggest
that protein fold change should not be used as threshold
for inclusion, but rather as an indicator of evolving events
occurring within the cell. A protein exhibiting a small fold
change at an early time point can be indicative of increasing
abundance thatmight be detected as significant at a later time.
The ability to detect a fold change at a particular level of
significance is intrinsically linked to the variance of the data,
and this variance is dependent on tissue source and process-
ing techniques (Fig. 2). It is therefore misguided to include
fold change in the initial stages of data dissection. A protein
reaching the threshold set by a stringent p-value (which in
its nature incorporates the variance and the magnitude of
change) should be sufficient for the initial inclusion crite-
rion, resulting in a much reduced but relevant list of protein
changes (Fig. 3).
The concept of excluding proteins based on fold change
not only increases the likelihood of making type II errors,
but is also fundamentally flawed given that the biological
relevance of a change in protein abundance is likely to be
protein specific. For example, proteins in the Bcl-2 family are
important evolutionarily conserved regulators of apoptosis.
However, even within this family, certain proteins are more
influential than others: PUMA (p53upregulatedmodulator of
apoptosis) being one of the most potent [13]. Subtle changes
in this protein are likely to have important cellular effects;
however, may be ruled out if stringent fold change cut-offs
are employed when analyzing data. The importance of subtle
protein changes needs to be recognized in the analysis of
large proteomic datasets to avoid the loss of valuable data
through the use of inappropriate fold change cut-offs.
The issue of multiple hypothesis testing, where inves-
tigating changes in many separate proteins can lead to
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Figure 3. Arbitrary fold change cut-offs are associated with the increased likelihood false negatives. (A) Employing the common “minimum
1.5 fold change” inclusion criterion on datasets with low overall variance drastically reduces the number of proteins available for analysis.
A stringent alpha value of p < 0.01 reduces the number of proteins in from 958 identified with two or more peptides to 193. Imposing an
additional fold change cut-off of 1.5 on this reduced protein list results in a final list for analysis containing only 34 proteins. (B) Analysis
of the more variable microvessel enrichment data demonstrates that a stringent alpha value of p < 0.01 reduces the number of proteins
available for analysis from 653 identified with two or more peptides to only 12. Imposing a 1.5 fold change cut-off has no further effect
on protein number, due to a large fold change required to overcome the variance for inclusion at the set alpha threshold. (C) Biologically
relevant protein GRP78 is significantly increased following a severe metabolic challenge (18 h OGD), and undergoes a fold change increase
of 1.53 from control to OGD samples. This protein would be included for further analysis in most proteomic studies (D) Biologically related
protein GRP94 is also significantly increased following a severemetabolic challenge (18 h OGD), however, undergoes a fold change increase
of 1.48. This protein would be excluded from further analysis in most proteomic studies, demonstrating the arbitrary and irrelevant nature
of fold change inclusion criteria. Each data point in C and D represent an independent biological replicate (n = 6 for each condition).
significant results purely by chance, is an important and
widely reviewed issue that is not formally dealt with in this
article [4, 14–16]. However, consideration should be given to
the fact that overly stringent corrections for multiple compar-
isons can limit the ability to glean biologically meaningful
conclusions from data. Typical methods, such as the Bonfer-
roni correction, are too stringent when studying changes in
hundreds of gene or protein abundances in microarray and
proteomic experiments. A less stringent method for dealing
with multiple comparisons is to employ the false discovery
rate, described by Benjamini andHochberg, based on the fre-
quency distribution of the statistically generated p-values [17].
It must be noted that a level of arbitrariness remains when
implementing a false discovery rate. The rate of incorrectly
rejecting the null hypotheses is chosen by the individual,
depending on the perceived acceptability of false-positives re-
maining in the final dataset.
As proteomic technology advances, it is important to re-
member where the true power of proteomics lies: as a hy-
pothesis generator and a tool for generating candidates of
potential biomarkers and drug targets of disease. The utility
of proteomics is greatest when a maximum number of pro-
teins are identified and included for further analysis. Data
processing techniques such as an initial inclusion of a pro-
tein identification threshold of two or more peptides give the
researcher confidence in the protein identification. Statistical
significance should then be considered as a sufficient thresh-
old in detecting important protein changes. Pushing proteins
to clear too many hurdles on their way to the final dataset in-
creases the likelihood of omitting biologically interesting and
relevant data.
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